Lewis Clayton Cantley Jr., Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 10,664 shares at $66.16 ($692K) on 2015-12-29, disclosed to the SEC on 2015-12-29.
Scheduled sale ($692k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.72 | 2,662 | $170K | 24.5% |
| 2 | $63.73 | 2,662 | $170K | 24.5% |
| 3 | $66.11 | 2,670 | $177K | 25.5% |
| 4 | $66.16 | 2,670 | $177K | 25.5% |
| Total | $64.93 avg | 10,664 | $692K | 100% |
| Filing → |
| AGIO | SELL | 2017-10-18 | $142K | — | Filing → |
| AGIO | SELL | 2017-09-15 | $131K | — | Filing → |
| AGIO | SELL | 2017-08-24 | $114K | — | Filing → |